MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis

被引:15
作者
Chen, Liangyuan [1 ]
Cui, Zhaolei [1 ]
Liu, Yaohua [1 ]
Bai, Ye [1 ]
Lan, Fenghua [1 ]
机构
[1] Fuzhou Gen Hosp, Dept Clin Genet & Expt Med, Fuzhou, Fujian, Peoples R China
关键词
bladder cancer; meta-analysis; microRNA; diagnosis; EXPRESSION PROFILES; TUMOR-MARKERS; URINE; IDENTIFICATION; SENSITIVITY; STATISTICS; TESTS; RNA;
D O I
10.7754/Clin.Lab.2015.150204
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Bladder cancer (BCa) is the fifth most common cancer with significant morbidity and mortality. Recently, numerous studies demonstrated that microRNAs (miRNAs) are emerging as diagnostic biomarkers for BCa. However, the findings in these studies are inconsistent. To systematically assess the potential diagnostic value of miRNAs for BCa, a meta-analysis was performed in this study. Methods: Relevant literature was researched in PubMed, Embase, Cochrane Library, Chinese National Knowledge Infrastructure (CNKI), and WanFang databases up to September 1, 2014. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative LR (NLR), diagnostic odds ratio (DOR), and area under the SROC curve (AUC) value were analyzed by the random-effects model, whose parameters reflected the overall diagnostic performance of miRNAs. Results: Thirty studies from 10 individual publications, including 1019 BCa patients and 690 controls, were included in this meta-analysis. The pooled sensitivity, specificity, PLR, NLR, DOR, and AUC were 0.80 (95% CI: 0.78 - 0.81), 0.74 (95% CI: 0.72 - 0.76), 3.22 (95% CI: 2.68 - 3.87), 0.26 (95% CI: 0.21 - 0.32), 15.20 (95% CI: 10.25 - 22.53) and 0.85, respectively, indicating a moderate diagnostic accuracy for BCa. Moreover, our subgroup analyses showed that analysis of multiple miRNAs (AUC, sensitivity, and specificity of 0.913, 0.86, and 0.80, respectively) yielded a higher diagnostic accuracy than of single miRNAs (AUC, sensitivity, and specificity of 0.84, 0.78, and 0.73, respectively) in BCa diagnosis. In addition, as biomarkers, miRNAs are more suitable for the diagnosis of non-muscle-invasive BCa (NMIBCa) with AUC of 0.84, sensitivity of 0.74, and specificity of 0.77 than muscle-invasive BCa (MIBCa) with AUC of 0.79, sensitivity of 0.73, and specificity of 0.73. Conclusions: The present meta-analysis suggests that miRNAs are potential novel biomarkers for detection of BCa. However, further validation studies are still needed to confirm our findings.
引用
收藏
页码:1101 / 1108
页数:8
相关论文
共 28 条
[1]   Bladder cancer biomarkers: current developments and future implementation [J].
Alvarez, Alonso ;
Lokeshwar, Vinata B. .
CURRENT OPINION IN UROLOGY, 2007, 17 (05) :341-346
[2]  
Bhatt J, 2012, EXPERT REV ANTICANC, V12, P929, DOI [10.1586/ERA.12.73, 10.1586/era.12.73]
[3]   Letter to the editor [J].
Chu, Haitao ;
Guo, Hongfei .
BIOSTATISTICS, 2009, 10 (01) :201-203
[4]   The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed [J].
Deeks, JJ ;
Macaskill, P ;
Irwig, L .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (09) :882-893
[5]   Statistics notes - Diagnostic tests 4: likelihood ratios [J].
Deeks, JJ ;
Altman, DG .
BRITISH MEDICAL JOURNAL, 2004, 329 (7458) :168-169
[6]   The diagnostic odds ratio: a single indicator of test performance [J].
Glas, AS ;
Lijmer, JG ;
Prins, MH ;
Bonsel, GJ ;
Bossuyt, PMM .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2003, 56 (11) :1129-1135
[7]   Micro-RNA profiling in kidney and bladder cancers [J].
Gottardo, Fedra ;
Liu, Chang Gong ;
Ferracin, Manuela ;
Calin, George A. ;
Fassan, Mattect ;
Bassi, Pierfrancesco ;
Sevignani, Cinzia ;
Byrne, Dolores ;
Negrini, Massimo ;
Pagano, Francesco ;
Gomella, Leonard G. ;
Croce, Carlo M. ;
Baffa, Raffaele .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (05) :387-392
[8]   Identification of novel microRNA targets based on microRNA signatures in bladder cancer [J].
Ichimi, Takahiro ;
Enokida, Hideki ;
Okuno, Yasushi ;
Kunimoto, Ryo ;
Chiyomaru, Takeshi ;
Kawamoto, Ken ;
Kawahara, Kazuya ;
Toki, Kazuki ;
Kawakami, Kazumori ;
Nishiyama, Kenryu ;
Tsujimoto, Gozoh ;
Nakagawa, Masayuki ;
Seki, Naohiko .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (02) :345-352
[9]   The MicroRNA Expression Signature of Bladder Cancer by Deep Sequencing: The Functional Significance of the miR-195/497 Cluster [J].
Itesako, Toshihiko ;
Seki, Naohiko ;
Yoshino, Hirofumi ;
Chiyomaru, Takeshi ;
Yamasaki, Takeshi ;
Hidaka, Hideo ;
Yonezawa, Tomokazu ;
Nohata, Nijiro ;
Kinoshita, Takashi ;
Nakagawa, Masayuki ;
Enokida, Hideki .
PLOS ONE, 2014, 9 (02)
[10]   Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer [J].
Jiang, Xiumei ;
Du, Lutao ;
Wang, Lili ;
Li, Juan ;
Liu, Yimin ;
Zheng, Guixi ;
Qu, Ailin ;
Zhang, Xin ;
Pan, Hongwei ;
Yang, Yongmei ;
Wang, Chuanxin .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (04) :854-862